News
Tandem Diabetes Care
TNDM · NASDAQ
$16.52+$0.14 (+0.85%)TodayMarket closed ·
Prev close $16.38
Latest news
- Press releaseBusiness Wire
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026
- Press releaseBusiness Wire
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets
- NewsVandana Singh
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
- NewsVandana Singh
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
- NewsAvi Kapoor
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Upcoming Conference Presentation
- Press releaseBusiness Wire
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
- Press releaseBusiness Wire
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Press releaseBusiness Wire
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseBusiness Wire
Tandem Diabetes Care Announces First Quarter 2026 Financial Results
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
- Press releaseBusiness Wire
Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes
- NewsVandana Singh
FDA Flags High-Risk Recall For Tandem Diabetes Mobi Pumps
- Press releaseBusiness Wire
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
- NewsVandana Singh
Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence
- Press releaseBusiness Wire
Tandem Mobi Now Compatible with Android Smartphones
- Press releaseBusiness Wire
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
- NewsAvi Kapoor
Dow Jumps Over 200 Points After Court's Tariff Ruling: Investor Sentiment Improves, Greed Index Remains In 'Fear' Zone
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsAvi Kapoor
Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results
- NewsAvi Kapoor
Nasdaq Gains 1%; PPL Posts In-Line Q4 Earnings
- NewsAvi Kapoor
RingCentral Posts Upbeat Q4 Earnings, Joins Tandem Diabetes, AXT, Opendoor Technologies And Other Big Stocks Moving Higher On Friday
- News
Assessing Tandem Diabetes Care: Insights From 10 Financial Analysts
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
- Press releaseNewsfile
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
- Press releaseNewsfile
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
- Press releasePRNewswire
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
- News
Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views
- Press releaseNewsfile
ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
- Press releaseNewsfile
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
- Press releaseBusiness Wire
t:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States
- Press releaseBusiness Wire
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
- Press releaseBusiness Wire
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
- Press releaseBusiness Wire
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.